咳嗽辅助设备市场－全球产业规模、份额、趋势、机会和预测（按类型、按交付方式、按最终用户、按地区和竞争细分，2020-2030 年预测）

2024 年全球咳嗽辅助设备市场价值为 29.8 亿美元，预计到 2030 年将达到 45.5 亿美元，预测期内的复合年增长率为 7.45%。随着人们对呼吸健康的认识不断提高，以及肌萎缩性脊髓侧索硬化症 (ALS) 和肌肉营养不良症等慢性呼吸系统疾病的发病率不断上升，推动了市场的发展。咳嗽辅助设备，也称为机械充气-排气系统，用于帮助因神经肌肉疾病或脊髓损伤而无法有效咳嗽的患者。这些设备提供了一种清除呼吸道分泌物的非侵入性方法，可降低感染和住院风险。慢性病诊断率的提高、全球人口老化以及向居家照护的转变是推动市场成长的主要因素。此外，设备设计的进步（例如便携性、易用性和智慧连接功能）正在扩大其在机构和居家护理环境中的可及性和采用率。然而，高昂的设备成本以及低收入地区有限的可及性继续挑战市场渗透。儘管如此，对医疗基础设施、产品创新和呼吸照护意识的持续投资预计将维持市场发展势头，尤其是在新兴经济体。

关键市场驱动因素

慢性呼吸系统疾病盛行率上升

主要市场挑战

设备成本高

主要市场趋势

技术进步与人工智慧融合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球咳嗽辅助设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（自动和手动）
  • 依交付方式选择（面罩、咬嘴、转接器）
  • 按最终使用者（医院和诊所、门诊护理机构、家庭护理、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按选择交付
  • 按最终用户
  • 按地区

第六章：北美咳嗽辅助设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲咳嗽辅助设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区咳嗽辅助设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲咳嗽辅助设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲咳嗽辅助设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 13 章：竞争格局

• Koninklijke Philips NV
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems SA

第 14 章：策略建议

第15章调查会社について・免责事项

The Global Cough Assist Devices Market was valued at USD 2.98 billion in 2024 and is projected to reach USD 4.55 billion by 2030, expanding at a CAGR of 7.45% during the forecast period. The market is being driven by rising awareness around respiratory health and a growing prevalence of chronic respiratory illnesses such as ALS and muscular dystrophy. Cough assist devices, also known as mechanical insufflation-exsufflation systems, are used to assist patients who cannot cough effectively due to neuromuscular disorders or spinal cord injuries. These devices provide a non-invasive method for clearing airway secretions, reducing the risk of infections and hospitalizations. Increasing diagnosis of chronic conditions, an aging global population, and the shift toward home-based care are major factors contributing to market growth. Furthermore, advancements in device design-such as portability, ease of use, and smart connectivity features-are expanding access and adoption across both institutional and homecare settings. However, high equipment costs and limited access in lower-income regions continue to challenge market penetration. Nonetheless, ongoing investments in healthcare infrastructure, product innovation, and respiratory care awareness are expected to sustain market momentum, particularly in emerging economies.

Key Market Drivers

Rising prevalence of chronic respiratory diseases

The increasing incidence of chronic respiratory disorders is a key driver for the global cough assist devices market. Conditions such as COPD, asthma, bronchiectasis, and neuromuscular diseases-including ALS and muscular dystrophy-impair the ability to clear airway secretions. For patients with weakened respiratory muscles, natural coughing becomes ineffective, making cough assist devices vital for secretion clearance and infection prevention. Factors such as air pollution, smoking, and occupational exposures are accelerating the burden of respiratory diseases, particularly in low- and middle-income countries. The rise in global life expectancy is also contributing to a larger elderly population at higher risk for respiratory complications. As healthcare providers prioritize early diagnosis and preventative care, there is a growing emphasis on integrating cough assist devices into long-term treatment plans. These devices are increasingly recommended to improve patient outcomes, reduce hospital visits, and support quality of life for those living with chronic respiratory conditions. This trend is especially significant in the homecare segment, where long-term respiratory support is essential.

Key Market Challenges

High cost of devices

The high cost associated with cough assist devices is a major constraint for market expansion. These devices entail significant upfront investment, in addition to recurring expenses related to accessories, servicing, and user training. For many patients-particularly in developing regions-the cost barrier prevents access to these crucial respiratory support tools. Reimbursement policies for such devices remain inconsistent across markets, further exacerbating out-of-pocket expenses for users. Limited funding and insurance coverage often discourage healthcare professionals from prescribing these devices, knowing that affordability may be an issue for patients. In homecare settings, this financial burden typically falls on families or caregivers, creating additional reluctance to invest in the technology. While innovations in design and features continue, they often raise production costs, which manufacturers then pass on to consumers. This pricing dynamic complicates efforts to scale adoption. Solutions such as expanded reimbursement, targeted subsidies, and the development of more affordable alternatives are needed to overcome this barrier and enhance access to life-improving respiratory devices.

Key Market Trends

Technological Advancements and AI Integration

The market is being reshaped by technological advancements and the integration of artificial intelligence (AI) into cough assist devices. Newer models feature compact, portable designs, improved pressure modulation, and user-friendly interfaces that make them more comfortable and efficient for daily use. AI-powered functionalities allow these devices to analyze cough patterns and respiratory metrics, aiding in the early diagnosis and monitoring of conditions like COPD and pneumonia. Real-time data collection and predictive analytics enable more precise, individualized treatment planning. Furthermore, smart connectivity features allow remote monitoring by healthcare professionals, enhancing continuity of care and minimizing hospital visits. These innovations are particularly beneficial in homecare environments, where constant clinical supervision is not feasible. Digital platforms also foster better communication among patients, caregivers, and medical teams, contributing to improved compliance and outcomes. As AI and smart features become more widespread, cough assist devices are expected to become increasingly personalized, adaptable, and aligned with the broader trend toward connected health ecosystems.

Key Market Players

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

Report Scope:

In this report, the Global Cough Assist Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cough Assist Devices Market, By Type:

• Automatic
• Manual

Cough Assist Devices Market, By Choice of Deliver:

• Face Mask
• Mouthpiece
• Adapter

Cough Assist Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Settings
• Homecare
• Others

Cough Assist Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cough Assist Devices Market.

Available Customizations:

Global Cough Assist Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cough Assist Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Automatic v/s Manual)
  • 5.2.2. By Choice of Delivery (Face Mask, Mouthpiece, Adapter)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Settings, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Choice of Delivery
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Cough Assist Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Choice of Delivery
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cough Assist Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Choice of Delivery
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Cough Assist Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Choice of Delivery
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Cough Assist Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Choice of Delivery
      • 6.3.3.2.3. By End User

7. Europe Cough Assist Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Choice of Delivery
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cough Assist Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Choice of Delivery
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Cough Assist Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Choice of Delivery
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Cough Assist Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Choice of Delivery
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Cough Assist Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Choice of Delivery
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Cough Assist Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Choice of Delivery
      • 7.3.5.2.3. By End User

8. Asia-Pacific Cough Assist Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Choice of Delivery
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cough Assist Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Choice of Delivery
      • 8.3.1.2.3. By End User
  • 8.3.2. India Cough Assist Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Choice of Delivery
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Cough Assist Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Choice of Delivery
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Cough Assist Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Choice of Delivery
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Cough Assist Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Choice of Delivery
      • 8.3.5.2.3. By End User

9. South America Cough Assist Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Choice of Delivery
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cough Assist Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Choice of Delivery
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Cough Assist Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Choice of Delivery
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Cough Assist Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Choice of Delivery
      • 9.3.3.2.3. By End User

10. Middle East and Africa Cough Assist Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Choice of Delivery
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cough Assist Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Choice of Delivery
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Cough Assist Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Choice of Delivery
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Cough Assist Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Choice of Delivery
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Koninklijke Philips N.V.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Hillrom Holdings, Inc.
• 13.3. Percussionaire Corp.
• 13.4. Dima Italia Srl
• 13.5. United Hayek Industries Inc
• 13.6. McKesson Medical-Surgical Inc.
• 13.7. Aetna Inc.
• 13.8. International Biophysics Corporation
• 13.9. PARI GmbH
• 13.10. Air Liquide Medical Systems S.A.

14. Strategic Recommendations

15. About Us & DIsclaimer